Analysts Anticipate Teva Pharmaceutical Industries Limited (NYSE:TEVA) Will Post Earnings of $0.55 Per Share

Wall Street brokerages expect Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Rating) to report earnings per share of $0.55 for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Teva Pharmaceutical Industries’ earnings. The highest EPS estimate is $0.61 and the lowest is $0.50. Teva Pharmaceutical Industries posted earnings of $0.63 per […]

Related Keywords

United States ,America ,Sanfordc Bernstein ,Sven Dethlefs ,Huntington National Bank ,Securities Exchange Commission ,Fieldpoint Private Securities ,Teva Pharmaceutical Industries Company Profile Get Rating ,Zacks Investment Research ,Koshinski Asset Management Inc ,Teva Pharmaceutical Industries Limited ,Financial Wealth Managment ,Kistler Tiffany Companies ,Teva Pharmaceutical Industries ,Barclays ,Wall Street ,Get Rating ,Teva Pharmaceutical Industrie ,Pharmaceutical Industries ,Teva Pharmaceutical ,Investment Research ,Exchange Commission ,Matthew Stark ,Private Securities ,Asset Management ,Tiffany Companies ,National Bank ,Future Financial Wealth Managment ,Pharmaceutical Industries Company Profile ,Pharmaceutical Industries Limited ,North America ,Nyse Teva ,Teva ,Medical ,Ratings ,Consensus ,